#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14366	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2111	675.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	845	C	790	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	745.8	0	.	n	.	0	T695C	SNP	695	695	T	991	991	C	777	C,T	728,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	745.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1934	1934	G	836	G	791	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	745.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2267	2267	C	821	C	769	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	745.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2341	2341	A	846	A	805	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	745.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2893	2893	C	794	C,T	737,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	131.1	0	.	p	.	0	S68P	NONSYN	202	204	TCG	453	455	CCG	184;186;189	C;C;G	169;170;175	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	131.1	0	.	p	.	0	A204V	NONSYN	610	612	GCA	861	863	GTA	195;196;194	G;T,C;A	189;187,1;186	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	131.1	1	SNP	p	R228S	1	.	.	682	684	AGC	933	935	AGC	193;193;193	A;G;C	182;183;181	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5254	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3235	161.6	1	SNP	p	S91F	1	.	.	271	273	TTC	514	516	TTC	165;169;171	T;T;C	158;163;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5254	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3235	161.6	1	SNP	p	G95N	0	.	.	283	285	GGC	526	528	GGC	171;168;167	G;G;C	161;156;157	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5254	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3235	161.6	1	SNP	p	D95G	1	.	.	283	285	GGC	526	528	GGC	171;168;167	G;G;C	161;156;157	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1680	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1413	118.5	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	210;209;208	G;G;C	197;198;194	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	874	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1047	83.1	0	.	n	.	0	A197.	DEL	197	197	A	570	570	A	172	A	160	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5052	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3301	152.6	1	SNP	p	D86N	0	.	.	256	258	GAC	792	794	GAC	189;190;191	G;A;C	177;178;179	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5052	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3301	152.6	1	SNP	p	R87W	0	.	.	259	261	CGT	795	797	CGT	192;192;193	C;G;T	180;180;179	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5052	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3301	152.6	1	SNP	p	S87R	1	.	.	259	261	CGT	795	797	CGT	192;192;193	C;G;T	180;180;179	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5052	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3301	152.6	1	SNP	p	R87I	0	.	.	259	261	CGT	795	797	CGT	192;192;193	C;G;T	180;180;179	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5052	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3301	152.6	1	SNP	p	S88P	0	.	.	262	264	TCC	798	800	TCC	190;192;190	T;C;C	175;181;180	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4386	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2540	171.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	219;217;213	G;G;C	210;207;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1223	1225	GCC	250;252;255	G;C;C	230;235;238	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1226	1228	ATG	252;250;252	A;T;G	233;234;233	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1238	1240	ACC	244;242;241	A;C;C	225;223;224	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1238	1240	ACC	244;242;241	A;C;C	225;223;224	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1739	1741	ACC	204;205;205	A;C;C	185;190;193	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1793	1795	GCG	205;205;199	G;C;G	191;193;189	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1793	1795	GCG	205;205;199	G;C;G	191;193;189	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1916	1918	GGT	149;148;148	G;G;T	135;134;131	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1925	1927	AGC	143;143;143	A;G;C	129;131;127	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3954	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2350	167.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1943	1945	CCG	131;133;127	C,G;C,G;G	97,8;99,1;92	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5524	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	2984	184.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1614	1616	CCG	207;207;210	C;C;G	185;192;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2464	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1844	133.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	535	535	C	167	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1523	181.5	1	SNP	p	G120K	1	.	.	358	360	AAG	618	620	AAG	220;220;219	A,G;A,G;G,C	209,1;209,1;205,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1523	181.5	1	SNP	p	N121D	0	.	.	361	363	AAC	621	623	AAC	218;216;219	A;A,G;C	209;208,1;207	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2788	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1523	181.5	1	SNP	p	A121N	1	.	.	361	363	AAC	621	623	AAC	218;216;219	A;A,G;C	209;208,1;207	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9648	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4728	203.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1004	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1048	95.4	1	SNP	p	V57M	1	.	.	169	171	ATG	525	527	ATG	208;208;205	A;T;G	194;193;192	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
